Whole Cell Production of Fine Chemicals and Intermediates

Biocatalysis for Green Chemistry and Chemical Process Development

Volumn , Issue , 2011, Pages 299-326

  Robins, Karen ^a   Gordon, John ^b  

^a LES R and D Evaluations and Business Process Excellence ^*

^b LONZA AG   (Switzerland)

Author keywords

(S) ( ) 2; 2 Dimethylcyclopropane carboxamide a chiral intermediate for cilastatin production; A renal dehydropeptidase inhibitor; Intermediates for pharmaceutical synthesis; Regiospecifically hydroxy substituted aromatic N heterocyclic carboxylic acids enabling effective synthesis; Whole cell production of fine chemicals and intermediates

Indexed keywords

EID: 84885974950     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9781118028308.ch12     Document Type: Chapter

References (55)

1. Paul TA, Warner JC. Green chemistry: theory and practice. Oxford, Oxford University Press; 1998.
2. Gerritzen D. Oekonomie und Oekologie im Einklang-nachhaltige chemische Production am Beispiel des Lonza-Produktionsverbundes in Visp. 7. Freiburger Symposium der Division Industrielle Chemie/Swiss Chemical Society, Nachhaltige chemische Produktion ''22nd & 23rd September; 2005.
3. Gulewitsch W, Krimberg R. Zur kenntnis der extraktivstoff der muskeln. Hoppe- Seyler's Z Physiol Chem 1905;45:326-330.
4. Tomita M, Sendju Y. Ueber die Oxyaminoverbindungen, welche die Biuretreaktion zeigen. III. Spaltung der ?-Amino-ß-oxy-buttersaeure in die optischaktiven Komponenten. Hoppe-Seyler's Z Physiol Chem 1927;169:263-277.
5. Friedman S, Fraenkel GS. New and unidentified growth factors. III. Carnitine. In: Sebrell WH Jr, Harris RS, editor. The Vitamins. New York. Academic Press; 1972. pp. 329-355.
6. Barlett K, Eaton S. Mitochondrial ß-oxidation. Eur J Biochem 2004;271:462-469.
7. Mueller DM, Seim H, Kiess W, Loester H, Richter T. Effects of oral L-carnitine supplementation on in vivo long chain fatty acid oxidation in healthy adults. Metabolism 2002;51(11):1389-1391.
8. Voeffray R, Perlberger J-C, Tenud L. L-carnitine. Novel synthesis and determination of the optical purity. Helv Chim Acta 1987;70:2058-2064.
9. Scholte HR, De Jonge PC. Metabolism, function and transport of carnitine in health and disease. In: Gitzelmann R, Baerlocher K, Steinmann B, editors. Carnitin in der medizin. Stuttgart: Schattauer; 1987. pp. 21-59.
10. Hardt P, Eyer M. Preparation of betaines from lactones and tertiary amines, Lonza. CH 687984. ;1993.
11. Kulla H. Enzymatic hydroxylations in industrial application. Chimia 1991;45:81-85.
12. Hoeks FWJMM. Process for the microbiological discontinual preparation of Lcarnitine Lonza. EP 0410430.; 1991.
13. Kulla H, Lehky P. Process for the production of L-carnitine in a microbiological way. Lonza. EP 0158194.; 1985.
14. Kulla H, Lehky P, Squaratti A. Process for the continuous production of L-carnitine Lonza. EP 0195944.; 1986.
15. Hoeks FWJMM, Kulla H, Meyer H-P. Continuous process cell-recycling with for L-carnitine production: performance, engineering and downstream process aspects compared with discontinuous processes. J Biotechnol 1992;22:117-128.
16. Zimmermann TP, Robins KT, Hoeks FWJM. Bio-transformation in the Production of L-Carnitine. In: Collins AN, Sheldrake GN, Crosby J, editors. Chirality in industry. Chichester. John Wiley & Sons, Ltd.; 1997. pp. 287-305.
17. Meyer H-P, Robins K. Large scale bioprocess for the production of optically pure L-carnitine. Chem Mon 2005;136:1269-1277.
18. Chuck R. A catalytic green process for the production of niacin. Chimia 2000; 54:508-513.
19. Sheldon RA. The E factor: fifteen years on. Green Chem 2007;9:1273-1283.
20. Bergamin RA. Produktionsintegrierter umweltschutz in der praxis am fallbeispiel der nicotinsáureproduktion CONCEPT-symposiums. Produktionstechnik unter Umweltaspekten; 1991; Mannheim.
21. Chuck R. Technology development in nicotinate production. Appl Catal A Gen 2005;280:75-82.
22. Chuck R. Green sustainable chemistry in the production of nicotinates. Ist International IUPAC Conference on Green-Sustainable Chemistry; 2006.
23. Heveling J, Ambruster E, Utiger L, Rohner M, Dettwiler H-R, Chuck RJ. Process for the preparation of nicotinic acid amide Lonza AG, Switzerland. EP 0770687.; 1997.
24. Nagasawa T, Mathew CD, Mauger J, Yamada H. Nitrile hydratase-catalyzed production of nicotinamide from 3-cyanopyridine in Rhodococcus rhodochrous J1. Appl Environ Microbiol 1988;54:1766-1769.
25. Nagasawa T, Takeuchi K, Yamada H. Characterization of a new cobalt-containing nitrile hydratase purified from urea-induced cells of Rhodococcus rhodochrous J1. Eur J Biochem 1991;196:581-589.
26. Sheldon RA, Arends I, Hanefeld U. Preface from the authors. Green chemistry and catalysis. Weinheim: Wiley-VCH; 2007.
27. Shaw NM, Naughton A, Robins K, Tinschert A, Schmid E, Hischier M-L, Venetz V, Werlen J, Zimmermann T, Brieden W, de Riedmatten P, Roduit J-P, Zimmermann B, Neumueller R. Selection, purification, characterisation, and cloning of a novel heat-stable stereo-specific amidase from Klaebsiella oxytoca, and its application in the synthesis of enantiomerically pure (R)- and (S)-3,3,3-trifluoro-2-hydroxy-2- methylpropionic acids and (S)-3,3,3-trifluoro-2-hydroxy-2-methylpropionamide. Org Process Res Dev 2002;6:497-504.
28. Eichhorn E, Roduit J-P, Shaw N, Heinzmann K, Kiener A. Preparation of (S)- piperazine-2-carboxylic acid, (R)-piperazine-2-carboxylic acid, and (S)-piperidine- 2-carboxylic acid by kinetic resolution of the corresponding racemic carboxamides with stereoselectiv amidases in whole bacterial cells. Tetrahedron: Asymmetry 1997;8(15):2533-2536.
29. Hanselmann P. Process for the preparation of cyclopropanenitrile derivatives. EP 0491323.; 1992;
30. Meul T, Kaempfen U. Process for the preparation of dimethylcyclopropancarboxylic acid. EP 0491330.; 1992.
31. Robins KT, Gilligan T. Biotechnological process for the production of (S )-(+)- 2,2-dimethylcyclopropane carboxamide and (R)-(-)-2,2-dimethylcyclopropane carboxylic acid. EP 0502525.; 1992.
32. Birch OM, Boehlen E, Gilligan T, Hoeks FWJMM, Malanik V, Robins K, Shaw NM, Zimmermann T. Development of an industrial process for S-2,2- dimethylcyclopropanecarboxamide. Chiral Europe '94; 1994.
33. Zimmermann T, Robins K, Birch O, Boehlen L. Process for the preparation of (S )-(+)-2,2-dimethyl-cyclopropane carboxamide by genetically engineered microorganisms. EP 0524 604.; 1993.
34. Lehky P, Kulla H, Mischler S. Process for the preparation of 6-hydroxynicotinic acid. EP0152948.; 1985.
35. Kiener A. Microbiological process for the preparation of 6-hydroxy nicotinic acid from 3-cyanopyridine. EP 504819.; 1992.
36. Kiener A. Microbiological process for the preparation of 6-hydroxy picolinic acid from 2-cyanopyridine. EP 504818.; 1992
37. Kiener A, Gloeckler R, Heinzmann K. Preparation of 6-oxo-1,6-dihydropyridine-2-carboxylic acid by microbial hydroxylation of pyridine-2-carboxylic acid. J Chem Soc [Perkin Trans 1] Organic and Bio-Organic Chemistry (1072-1999) 1993;11:1201-1202.
38. Wieser M, Heinzmann K, Kiener A. Bioconversion of 2-cyanopyrazine to 5- hydroxypyrazine-2-carboxylic acid with Agrobacterium sp. DSM 6336. Appl Microbiol Biotechnol 1997;48(2):174-176.
39. Kiener A, Van Gameren Y, Bokel M. US 5284767.; 1994.
40. Roduit JP, Wellig A, Kiener A. Renewable functionalised pyridines derived from microbial metabolites of the alkaloid (S)-nicotine. Heterocycles 1997;45(9): 1687-1702.
41. Buckingham S, Lapied B, Corronc H, Sattelle F. Imidocloprid actions on insect neuronal acetylcholine receptors. J Exp Biol 1997;200:2685-2692.
42. Quarroz D. Process for the preparation of 2-halogen-pyridine derivatives. EP 0084118.; 1983.
43. 406. Amiloride. The Merck Index, 10th EditionMerck & Co, USA.; 1983.
44. 4302. Glipicide. The Merck Index, 10th Edition Merck & Co, USA.; 1983.
45. 7858. Pyrazinamide. The Merck Index, 10th Edition Merck & Co, USA.; 1983.
46. Kiener A. Microbiological manufactures of 5-hydroxypyrazine carboxylic acid. EP 519512.; 1992.
47. Kiener A. Biosynthesis of functionalized aromatic N-heterocycles. Chemtech 1995;25:31-35.
48. Kiener A. Enzymatic oxidation of methyl groups on aromatic heterocycles: a versatile method for the preparation ofheteroaromatic carboxylic acids. Angew Chem Int Ed Engl 1992;31(6):774-775.
49. Orsini G, Lovisolo PP, Chiari A, Branzoli U. Effect of the antilipolytic compound acipimox on peroxisome marker enzymes, lipid pattern.; 1985.
50. Jarvis LM. Pfizer buys Wyeth. Chem Eng News 2009;87(5):7.
51. Matsuda H, Shibata T, Hashimoto H, Kitai M. Method for producing (R)-4-cyano-3- hydroxybutyric acid lower alkyl esters. US 5908953.; 1999.
52. Davis SC, Grate JH, Gray DR, Gruber JM, Huisman GW, Steven K, Newman LM, Sheldon R, Wang Li A. Enzymatic processes for the production of 4-substituted 3-hydroxybutyric acid derivatives. WO015132.; 2004.
53. Davis SC, Grate JH, Gray DR, Gruber JM, Huisman GW, Steven K, Newman LM, Sheldon R, Wang Li A. Enzymatic processes for the production of 4-substituted 3- hydroxybutyric acid derivatives and vicinal cyano, hydroxy substituted carboxylic acid esters. WO018579.; 2005.
54. Davis CS, Fox RJ, Gavrilovic V, Huisman GW, Newman LM. Improved halohydrin dehalogenases and related polynucleotides. WO2005017141.; 2005.
55. Ritter SK. Going green keeps getting easier. Chem Eng News 2006;84(28):24-27.